The BNMS is pleased to publish the report on the 'Future Supply of Medical Radioisotopes for the UK 2014'. In context of the impending closure of two of the world's nuclear reactors involved in the production of Molybdenum, the report assesses the potential impact of this on healthcare services in the UK. The report describes predicted shortages in the Molybdenum supply chain in the period 2016 to 2020, the current status of Nuclear Medicine services in the UK, and explores ways of mitigating the impact of these shortages on patient care pathways. The report additionally explores options for non-reactor production of Technetium-99m in the UK and incorporates details of a visit to the Cyclotron Facilities at Edmonton, Alberta and at TRIUMF, Vancouver BC in Canada by members of the report team.
Established in 1966 as the Nuclear Medicine Society, its membership includes the clinicians dealing with the medical speciality, clinical scientists, radiopharmacists, other scientists, nuclear medicine technologists and nurses.